Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment 2020-10-20 19:00
Samsung Biologics partners with BioEleven for cancer immunotherapy development and manufacturing 2020-10-19 19:00
Volition Veterinary Diagnostics Development LLC Announces Product Data Regarding its Nu.Q™ Vet Cancer Screening Test in Lymphoma and Hemangiosarcoma to be Presented at the 2020 VCS Virtual Annual Conference 2020-10-16 20:00
VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020 2020-10-14 20:00
Kanaph Therapeutics Closes 21M USD Series B Funding 2020-10-13 11:30
Gannex Received U.S. IND Approval for Its NASH Drug Candidate ASC42，an FXR Agonist 2020-10-12 08:30
Foresee Pharmaceuticals Announces NDA for CAMCEVI(TM) 42MG Accepted for Review by the FDA 2020-10-09 06:39
EB Research Partnership and EB Research Foundation Come Together as Largest Global Organization Advancing Research for Epidermolysis Bullosa 2020-10-08 21:00
Nagase R&D Center Increases Productivity of Rare Amino Acid "Ergothioneine" 1000-fold: Highest Production Efficiency Reported Using "Smart Cell" Technology 2020-10-07 14:00
CARsgen Therapeutics Granted Orphan Drug Designation by the US FDA for CT041 CLDN18.2 CAR-T Cells for the Treatment of Gastric and Gastroesophageal Junction Cancers 2020-10-05 18:00
Happiness Biotech Announced Receipt of FDA Registration For Its Hand Sanitizer 2020-10-01 22:00
TaiGen Biotechnology Out-Licensed Taigexyn (Nemonoxacin) to Luminarie Canada for Canada, Australia and New Zealand 2020-09-30 15:51
ILIAS Biologics Closes $20.6 Million Series B Financing 2020-09-28 19:00
World's first clinical trial of non-viral PD1 specific targeted CAR T therapy achieves great breakthroughs 2020-09-28 19:00
Carmine Therapeutics named as one of FierceBiotech's "Fierce 15" Biotech Companies of 2020 2020-09-28 18:00
Neurophth Therapeutics' Treatment of Leber's Hereditary Optic Neuropathy Gene Therapy NR082 was Granted Orphan Drug Designation by U.S. FDA 2020-09-25 10:37
KYAN Therapeutics Exclusively Licenses Small Molecule HDAC Inhibitors for AI-Powered Cancer Drug Development 2020-09-24 17:12
ImmVira Announces US$10 million Strategic Series B Plus Financing with SIIC Capital 2020-09-24 00:09
Minoryx Therapeutics and Sperogenix Therapeutics enter into an exclusive license agreement to develop and commercialize leriglitazone in mainland China, Hong Kong and Macau 2020-09-23 15:00
Cosmo PR and HekaBio Announce Strategic Partnership and Investment in HekaBio 2020-09-23 09:00
1 117 118 119 120 121 222